‘There’s No Hope for Any Kind of Decent Life’: A Qualitative Study to Explore the Perspectives of People Experiencing Homelessness with a Recent Non-Fatal Overdose in Scotland

The past ten years has seen a marked increase in the numbers of people experiencing homelessness globally and an associated public health epidemic of drug-related deaths. Drawing from qualitative interviews as part of a wider pilot randomised controlled trial (RCT) conducted in Glasgow, Scotland with National Health Service pharmacists and third sector homeless outreach caseworkers, insights from those with living experience of both homelessness and a recent non-fatal drug overdose will be presented. Twenty people experiencing homelessness with at least one drug overdose in the past six months were interviewed in person, in a homelessness drop in centre or in emergency accommodation between November 2021 and January 2022. Findings from our study indicate that participants’ drug use and overdose risk were exacerbated during the Covid-19 pandemic due to the pervasive availability of illicit drugs for those placed in emergency accommodation, alongside reduced support and access to health and social care services. Additionally, multi-agency stressors such as a lack of autonomy and dehumanising experiences were reported, leading to a significant sense of powerlessness. Furthermore, the necessity of advocacy-based services as critical aspects of support was identified, with importance placed upon dedicated, homelessness staff and access to safe environments.

[1]  David W. Brannan,et al.  Pharmacist and Homeless Outreach Engagement and Non-medical Independent prescribing Rx (PHOENIx): a study protocol for a pilot randomised controlled trial , 2022, BMJ Open.

[2]  C. Matheson,et al.  An avoidable crisis , 2022, Harm Reduction Journal.

[3]  Cylie M. Williams,et al.  Health professionals’ experience of implementing and delivering a ‘Community Care’ programme in metropolitan Melbourne: a qualitative reflexive thematic analysis , 2022, BMJ Open.

[4]  A. Stevens,et al.  The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation. , 2022, The International journal on drug policy.

[5]  C. Matheson,et al.  The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study , 2022, BMC Public Health.

[6]  C. Matheson,et al.  Assessing the feasibility, acceptability and accessibility of a peer-delivered intervention to reduce harm and improve the well-being of people who experience homelessness with problem substance use: the SHARPS study , 2022, Harm Reduction Journal.

[7]  K. Doran,et al.  Overdose and Homelessness-Why We Need to Talk About Housing. , 2022, JAMA network open.

[8]  T. Baggett,et al.  Drug Overdose Mortality Among People Experiencing Homelessness, 2003 to 2018 , 2022, JAMA network open.

[9]  C. Matheson,et al.  From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic. , 2021, The International journal on drug policy.

[10]  P. Stone,et al.  Barriers and facilitators to accessing health and social care services for people living in homeless hostels: a qualitative study of the experiences of hostel staff and residents in UK hostels , 2021, BMJ Open.

[11]  S. Hatcher,et al.  Interventions to treat post-traumatic stress disorder (PTSD) in vulnerably housed populations and trauma-informed care: a scoping review , 2021, BMJ Open.

[12]  A. Nyamathi,et al.  The impact of unstable housing on health. , 2021, The Lancet. Public health.

[13]  B. Christie Record drug deaths need radical response, says Scottish college , 2021, BMJ.

[14]  C. Matheson,et al.  Why are drug-related deaths among women increasing in Scotland? A mixed-methods analysis of possible explanations , 2020, Drugs.

[15]  V. Braun,et al.  Can I use TA? Should I use TA? Should I not use TA? Comparing reflexive thematic analysis and other pattern‐based qualitative analytic approaches , 2020 .

[16]  Iain McPhee,et al.  AUDIT Scotland 10 years on: explaining how funding decisions link to increased risk for drug related deaths among the poor , 2020 .

[17]  F. Mair,et al.  Pharmacist led homeless outreach engagement and non-medical independent prescribing (Rx) (PHOENIx) intervention for people experiencing homelessness: a non- randomised feasibility study , 2020, International Journal for Equity in Health.

[18]  H. Sumnall,et al.  High willingness to use drug consumption rooms among people who inject drugs in Scotland: findings from a national bio-behavioural survey among people who inject drugs , 2020, The International journal on drug policy.

[19]  J. Zibbell,et al.  Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. , 2019, The International journal on drug policy.

[20]  M. Nordentoft,et al.  Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis , 2017, The Lancet.

[21]  E. Hennessy Recovery capital: a systematic review of the literature , 2017 .

[22]  S. Gilmore,et al.  Work-worlds colliding: Self-reflexivity, power and emotion in organizational ethnography , 2015 .

[23]  A. O’Cathain,et al.  What can qualitative research do for randomised controlled trials? A systematic mapping review , 2013, Trials.

[24]  D. Best,et al.  From evidence to policy: The Scottish national naloxone programme , 2012 .